FOLH1 and prostate cancer: In prostate cancer (PCa), common imaging modalities include MRI, transrectal ultrasound, conventional CT, cone-beam CT, and molecular imaging techniques, particularly PET/CT with radiotracers such as radiolabeled PSMA and fluorine-18-labeled choline.